216 related articles for article (PubMed ID: 21507922)
21. High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti.
Weppelmann TA; Carter TE; Chen Z; von Fricken ME; Victor YS; Existe A; Okech BA
Malar J; 2013 Jan; 12():30. PubMed ID: 23347639
[TBL] [Abstract][Full Text] [Related]
22. The Duffy-null genotype and risk of infection.
Legge SE; Christensen RH; Petersen L; Pardiñas AF; Bracher-Smith M; Knapper S; Bybjerg-Grauholm J; Baekvad-Hansen M; Hougaard DM; Werge T; Nordentoft M; Mortensen PB; Owen MJ; O'Donovan MC; Benros ME; Walters JTR
Hum Mol Genet; 2020 Dec; 29(20):3341-3349. PubMed ID: 32959868
[TBL] [Abstract][Full Text] [Related]
23. Duffy blood group and malaria.
Langhi DM; Bordin JO
Hematology; 2006 Oct; 11(5):389-98. PubMed ID: 17607593
[TBL] [Abstract][Full Text] [Related]
24. Population genetic analysis of the DARC locus (Duffy) reveals adaptation from standing variation associated with malaria resistance in humans.
McManus KF; Taravella AM; Henn BM; Bustamante CD; Sikora M; Cornejo OE
PLoS Genet; 2017 Mar; 13(3):e1006560. PubMed ID: 28282382
[TBL] [Abstract][Full Text] [Related]
25. Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans.
Winkler CA; An P; Johnson R; Nelson GW; Kirk G
Cell Host Microbe; 2009 May; 5(5):411-3; author reply 418-9. PubMed ID: 19454340
[TBL] [Abstract][Full Text] [Related]
26. Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population.
Julg B; Reddy S; van der Stok M; Kulkarni S; Qi Y; Bass S; Gold B; Nalls MA; Nelson GW; Walker BD; Carrington M; Ndung'u T
Cell Host Microbe; 2009 May; 5(5):413-5; author reply 418-9. PubMed ID: 19454341
[No Abstract] [Full Text] [Related]
27. Molecular identification of Plasmodium species responsible for malaria reveals Plasmodium vivax isolates in Duffy negative individuals from southwestern Nigeria.
Oboh MA; Badiane AS; Ntadom G; Ndiaye YD; Diongue K; Diallo MA; Ndiaye D
Malar J; 2018 Nov; 17(1):439. PubMed ID: 30486887
[TBL] [Abstract][Full Text] [Related]
28. Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant.
Kim S; Eliot M; Koestler DC; Wu WC; Kelsey KT
JAMA Cardiol; 2018 Jun; 3(6):455-462. PubMed ID: 29801037
[TBL] [Abstract][Full Text] [Related]
29. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.
Peiper SC; Wang ZX; Neote K; Martin AW; Showell HJ; Conklyn MJ; Ogborne K; Hadley TJ; Lu ZH; Hesselgesser J; Horuk R
J Exp Med; 1995 Apr; 181(4):1311-7. PubMed ID: 7699323
[TBL] [Abstract][Full Text] [Related]
30. Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1)/Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele.
Davis MB; Walens A; Hire R; Mumin K; Brown AM; Ford D; Howerth EW; Monteil M
PLoS One; 2015; 10(10):e0140098. PubMed ID: 26473357
[TBL] [Abstract][Full Text] [Related]
31. Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function.
Mange KC; Prak EL; Kamoun M; Du Y; Goodman N; Danoff T; Hoy T; Newman M; Joffe MM; Feldman HI
Kidney Int; 2004 Sep; 66(3):1187-92. PubMed ID: 15327416
[TBL] [Abstract][Full Text] [Related]
32. Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.
Kelly DL; Glassman M; Wonodi I; Vyas G; Richardson CM; Nwulia E; Wehring HJ; Oduguwa T; Mackowick M; Hipolito MMS; Peters O; Rai N; Park J; Adebayo AO; Gorelick DA; Weiner E; Liu F; Kearns AM; Adams HA; Love RC; Chen S; Olaniyan A; Ambulos N; McKoy D; Nallani MC; Lanzkron S; Mengistab M; Barr B; Davis E; Lawal R; Buchanan RW; Adebayo R
Schizophr Res; 2024 Jun; 268():312-322. PubMed ID: 37633776
[TBL] [Abstract][Full Text] [Related]
33. Vivax malaria in Mauritania includes infection of a Duffy-negative individual.
Wurtz N; Mint Lekweiry K; Bogreau H; Pradines B; Rogier C; Ould Mohamed Salem Boukhary A; Hafid JE; Ould Ahmedou Salem MS; Trape JF; Basco LK; Briolant S
Malar J; 2011 Nov; 10():336. PubMed ID: 22050867
[TBL] [Abstract][Full Text] [Related]
34. Species-specific features of DARC, the primate receptor for Plasmodium vivax and Plasmodium knowlesi.
Demogines A; Truong KA; Sawyer SL
Mol Biol Evol; 2012 Feb; 29(2):445-9. PubMed ID: 21878684
[TBL] [Abstract][Full Text] [Related]
35. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.
Gunalan K; Lo E; Hostetler JB; Yewhalaw D; Mu J; Neafsey DE; Yan G; Miller LH
Proc Natl Acad Sci U S A; 2016 May; 113(22):6271-6. PubMed ID: 27190089
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
[TBL] [Abstract][Full Text] [Related]
37. HIV and chemokine binding to red blood cells--DARC matters.
Walton RT; Rowland-Jones SL
Cell Host Microbe; 2008 Jul; 4(1):3-5. PubMed ID: 18621004
[TBL] [Abstract][Full Text] [Related]
38. Correlation between 'ACKR1/DARC null' polymorphism and benign neutropenia in Yemenite Jews.
Rappoport N; Simon AJ; Lev A; Yacobi M; Kaplinsky C; Weingarten M; Somech R; Amariglio N; Rechavi G
Br J Haematol; 2015 Sep; 170(6):892-5. PubMed ID: 25817587
[No Abstract] [Full Text] [Related]
39. DARC alleles and Duffy phenotypes in African Americans.
Schmid P; Ravenell KR; Sheldon SL; Flegel WA
Transfusion; 2012 Jun; 52(6):1260-7. PubMed ID: 22082243
[TBL] [Abstract][Full Text] [Related]
40. The Duffy null genotype is associated with a lower level of CCL2, leukocytes and neutrophil count but not with the clinical outcome of HTLV-1 infection.
da Silva-Malta MCF; Sales CC; Guimarães JC; de Cássia Gonçalves P; Chaves DG; Santos HC; da Costa Pereira A; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML
J Med Microbiol; 2017 Aug; 66(8):1207-1216. PubMed ID: 28771137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
